Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

Connexin 30 is usually absent in normal skin but can appear in certain skin conditions.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Four specific genes are linked to keloid formation and could be potential treatment targets.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

Hair follicles and sweat glands show different keratin staining patterns.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Hair repigmentation can indicate malignancy and should be investigated.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

K15 is a reliable marker for studying stem cells in dog hair follicle tumors.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Bone marrow-derived cells can lead to skin inflammation and tumors in mice.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Kaposi's sarcoma lesions might originate from benign tissue changes.

ILC1-like cells can cause alopecia areata by affecting hair follicles.